MedPath

Pathogenic Mechanisms Involved in the Initiation and Progression of Systemic Sclerosis

Not Applicable
Not yet recruiting
Conditions
Scleroderma (Limited and Diffuse)
Registration Number
NCT07015060
Lead Sponsor
Université Catholique de Louvain
Brief Summary

Identify rare variants in candidate genes and pathways identified in familial SSc, in patients with sporadic SSc.

Perform (spatial) transcriptomic and proteomic analyses of affected skin from patients with and without cutaneous fibrosis, for the patterns and levels of expression/activation of candidate genes and pathways.

Test for dysregulation of expression/activation of candidate genes and pathways in live cells isolated from the blood and skin biopsy of patients, and for the impact of these dysregulations on cell appearance, behavior and function.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Patients diagnosed with one of the following:

    • Limited SSc
    • Limited cutaneous SSc
    • Diffuse cutaneous SSc
  • Patients followed regularly in consultations at CUSL.

  • Patients between ages 18-80.

Exclusion Criteria
  • Other (co-occurring) autoimmune/autoinflammatory disease
  • Pregnancy
  • Participants with temporary or definitive disabilities to give consent
  • Participants unable to sign or read the inform consent form

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Identify rare variants in candidate genes and pathways in SSC patients (blood and skin biopsy)Through the entire study, approximately during 5 years

Genetic analyses in affected skin from patients (Next Generation sequencing, (single cell) RNASeq, real time qPCR)

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath